Larvol Delta - Adlai-Nortye-Announces-First-Patient-Dosed-in-Intermittent-Weekly-Dosing-Arm-of-Global-Phase-1-Trial-of-PanRASON-Inhibitor-AN9025

AN9025 - Adlai Nortye

https://www.globenewswire.com/news-release/2026/07/16/3328326/0/en/Adlai-Nortye-Announces-First-Patient-Dosed-in-Intermittent-Weekly-Dosing-Arm-of-Global-Phase-1-Trial-of-Pan-RAS-ON-Inhibitor-AN9025.html

Jul 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next